Cirrhosis and portal hypertension
- Page Path
-
- HOME
- TOPICS
- Cirrhosis and portal hypertension
- Original Article
- Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma
- Soon Ha Kwon, Soung Won Jeong, Jae Young Jang, Ji Eun Lee, Sae Hwan Lee, Sang Gyune Kim, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, So-Young Jin
- Clin Mol Hepatol. 2012;18(3):287-294. Published online September 25, 2012
-
View: 7504 Download: 84 Crossref: 12
- Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis?
- Tae Wan Kim, Hong Joo Kim, Chang Uk Chon, Hyun Sun Won, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim
- Clin Mol Hepatol. 2012;18(2):203-212. Published online June 26, 2012
-
View: 7649 Download: 51 Crossref: 11
- A clinical predictor of varices and portal hypertensive gastropathy in patients with chronic liver disease
- Yang Won Min, So Young Bae, Geum-Youn Gwak, Yong Han Paik, Moon Seok Choi, Joon Hyoek Lee, Seung Woon Paik, Byung Chul Yoo, Kwang Cheol Koh
- Clin Mol Hepatol. 2012;18(2):178-184. Published online June 26, 2012
-
View: 8804 Download: 71 Crossref: 10
- Review
- Clinical applications of transient elastography
- Kyu Sik Jung, Seung Up Kim
- Clin Mol Hepatol. 2012;18(2):163-173. Published online June 26, 2012
-
View: 11711 Download: 121 Crossref: 79
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
- Immunopathogenesis of liver fibrosis in steatotic liver disease
- Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
- The role of the hepatic autonomic nervous system
- HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
- Systemic therapy in advanced hepatocellular carcinoma
- Epidemiology and updated management for autoimmune liver disease
- Microbiome and metabolomics in alcoholic liver disease
- Personalized medicine in nonalcoholic fatty liver disease
- Acute on chronic liver failure in cirrhosis
- Current status and outcome of liver transplantation in South Korea
- History and future of hepatitis B virus control in South Korea
- Hepatocellular carcinoma statistics in South Korea
Impact Factor8.9First decision
09 Days
Publication after acceptance
04 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2022-2024)
|
|||||||
